Well thanks for the profit and the money I made over the past year. Upside is still available and ACAD will high new highs, just think I can make another run from the $2.75 range to $20 over the next few months with PATH. Great potential, low float and FDA approved product. with a partnership or buyout I will be ahead of the game. Hope the best for ACAD investors but time to make my money multiply again with PATH.
Dr Wang, I see you have been accumulating CERS. What do you and your group think of XOMA and HALO? They are both getting a lot of chatter with recent large BB new purchases as well?Thanks for your thoughts! BTW . . . agree, anyone selling ACAD and not accumulating at this price making a big mistake. IMHO